Geiger Nitz + Partner - Kanzlei f├╝r Gesundheitsrecht

Dr. iur. Daniel Geiger

Top of the page
Dr. Daniel Geiger

Dr. Daniel Geiger

Dr. Daniel Geiger is a lawyer, a medical law specialist and a business mediator. He is a partner in the law firm Geiger Nitz + Partner Rechtsanw├Ąlte.

After studying law in Freiburg and Salzburg, he was awarded a doctorate for his dissertation on a healthcare law topic at the Institute for German, European and International Medical Law, Health Law and Bioethics at the universities of Heidelberg and Mannheim under Prof. Dr. Taupitz. He began his professional career in 2006 as a lawyer in the medical law team of an international law firm in their Hamburg office. In 2007 he joined the legal department of a research-based pharmaceutical company. There he attained the positions of Senior Legal Counsel, Head of Governance Risk & Compliance and Compliance Officer. In 2012, he transferred to a leading medical law firm in Berlin, initially as an associated partner, and became a full partner there in 2015. On 1.1.2017, he founded the law firm Geiger + Partner which has traded as Geiger Nitz und Partner since 1.1.2018.

Since 2008, he has been a member of various work committees in pharmaceutical industry associations (until 2012: VfA, since 2012: BPI). From 2009 until 2011, he was also a member of the board of the Voluntary Self-Regulation of the Pharmaceutical Industry Association (FSA). Since 2012, he has been a member of the "Healthcare Compliance Advisory Board" of the Pharmaceuticals and Cooperation in Healthcare Association (AKG), since 2014, a member of the Anti-Corruption Work Group of the Federal Pharmaceutical Industry Association (BPI) and since 2015, chairman of the "Healthcare Work Group" of the German Institute for Compliance (DICO).

He mainly advises healthcare service providers and companies regarding criminal law prevention and healthcare compliance issues. In this context, he provides comprehensive advice regarding collaborations in the healthcare sector. He also focuses on representing companies and individuals in civil disputes, in particular competition-related disputes, associations proceedings and criminal law investigations. He provides comprehensive advice regarding pharmaceutical law issues, especially those concerning clinical research as well. At the same time, he uses his legal knowledge and experience as the co-founder of a start-up in the area of digital health in order to offer advice on (start-up) projects in this field.

He teaches medical criminal law in the Medical Law LL.M. program at the Dresden International University (DIU), lectures in the area of healthcare compliance in the "Pharmaceutical Law" LL.M. program at Philipps University in Marburg and at the School of Governance Risk & Compliance at the Steinbeis-Hochschule Berlin. He has written numerous specialist articles on pharmaceutical law, healthcare compliance and medical criminal law.

His competitors describe him as "extremely skilled in the area of compliance" (JUVE Handbuch 2014/2015), while his clients report that he has "profound expertise" in medical products advertising law (JUVE Handbuch 2016/2017). In 2017, the American survey "Best Lawyers in Germany" nominated him to the Pharmaceuticals Law category. This was followed by a Handelsblatt nomination in the same category to the "Germany's best lawyers in 2017" list.

He advises clients in German and English.

His publications and presentations


Dr. Daniel Geiger - Best Lawyers - Handelsblatt

Dr. Daniel Geiger - Best Lawyers - Handelsblatt



ÔÇ×Tiefe Expertise an der Schnittstelle zwischen Heilmittelwerbegesetz und ErstattungsrechtÔÇť

Mandant,
Juve Handbuch 2016/2017


ÔÇ×├äu├čerst kompetent im Bereich Compliance.ÔÇť

Wettbewerber,
Juve Handbuch 2014/2015



















Dr. Gerhard Nitz - Best Lawyers - Handelsblatt

Dr. iur. Gerhard Nitz

Top of the page
Dr. Gerhard Nitz

Dr. Gerhard Nitz is a lawyer and a specialist in medical law. He is a partner in the law firm Geiger Nitz + Partner Rechtsanw├Ąlte.

After studying law in Mainz, Dijon and Bielefeld, he initially worked as a research assistant at the chair of Prof. Dr. Chr. Gusy for public law, political science and constitutional history in Bielefeld. In 2000, between research stints in Michigan and Paris, he was awarded a doctorate here for his dissertation on a constitutional and administrative law topic ("Private and Public Security").

From 2001 until 2017, he was a lawyer at one of the leading medical law firms in Germany and became a partner of the firm in 2008. In 2018, he then joined up with his current partners to establish Geiger Nitz + Partner, a legal firm specializing in healthcare law.

Gerhard Nitz mainly advises pharmaceutical companies and physicians regarding statutory health insurance and pharmaceutical law including constitutional and European legal issues. In light of his experience with panel physicians, he focuses on advising pharmaceutical companies on market access and reimbursement issues, in particular on the AMNOG. He also focuses on prescription management measures of the medical self-administration. As well he uses his experience of the regulation of the pharmaceuticals market when advising clients on related problems in the area of non-medicinal examination and treatment methods.

He regularly gives talks and publishes articles about these topics in medical and legal literature. Given his high level of specialization and his in-depth experience, the sector information service Juve added his name to the list of the nine "leading names in pharmaceutical and medical product law" in 2017.

He advises clients in German, English and French.





Sarah Yacob

Top of the page
Sarah Yacob

Sarah Yacob is a lawyer and partner in the law firm Geiger Nitz + Partner Rechtsanw├Ąlte.

She studied German and international law at Humboldt University in Berlin and the University of Geneva in Switzerland, with a focus on criminal law. Both as an intern and during her traineeship, she worked in compliance and commercial criminal law in various international business law firms.

She began her professional career at one of the leading medical law firms in Berlin before she joined Daniel Geiger to establish a law firm of her own. She mainly advises pharmaceutical companies, manufacturers of medical devices, hospitals as well as physicians and pharmacists regarding all healthcare compliance, anti-corruption and medical criminal law issues. She focuses on collaborations in the healthcare sector. She also advises clients on integrity and healthcare advertising issues and represents them during competition proceedings. At the same time, she specializes in defending the manufacturers of medical devices against claims for compensation as part of civil product liability proceedings. She regularly gives talks at conferences on healthcare compliance and medical criminal law. She wrote an article on healthcare advertising law and competition law and on pharmaceutical self-regulation that appeared in the Handbook on Healthcare Compliance published by Beck Verlag.

She advises clients in German, English and French.

Her publications and presentations





J├Ârn Grotjahn

Top of the page
J÷rn Grotjahn

J├Ârn Grotjahn is a lawyer and partner in the law firm Geiger Nitz + Partner Rechtsanw├Ąlte.

He studied history, political sciences and German studies in G├Âttingen and Oxford (Master of Studies, M.St.) as well as law at the Free University of Berlin. During his studies and traineeship, he worked as a parliamentary assistant at the German Bundestag.

He began his career as a lawyer at one of the leading legal firms specializing in medical law in Berlin, where he spent a number of years advising clients on social insurance and regulatory issues affecting the supply of medicinal products. His advisory work focuses on market access as well as pricing and reimbursement. In particular, he assists German and international clients during AMNOG negotiations regarding reimbursement for new medicinal products, during arbitration proceedings and in legal disputes.

He regularly speaks about the supply of medicinal products and AMNOG at specialist events. He is a commentator on the AMNOG negotiations in the Nomos Health Law Commentary (2nd edition 2018) and the author of numerous articles in pharmaceutical magazines.

He advises clients in German and English.


Dr. Daniel Geiger - Best Lawyers - Handelsblatt

Dr. Daniel Geiger - Best Lawyers - Handelsblatt